MARKET

ORGS

ORGS

Orgenesis Inc
EXMKT
0.750
+0.580
+341.18%
Closed 10:12 12/04 EST
OPEN
0.750
PREV CLOSE
0.170
HIGH
0.750
LOW
0.750
VOLUME
100
TURNOVER
75
52 WEEK HIGH
5.38
52 WEEK LOW
0.0001
MARKET CAP
4.80M
P/E (TTM)
-0.0800
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ORGS last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at ORGS last week (1117-1121)?
Weekly Report · 11/24 10:27
Weekly Report: what happened at ORGS last week (1110-1114)?
Weekly Report · 11/17 10:27
Weekly Report: what happened at ORGS last week (1103-1107)?
Weekly Report · 11/10 10:25
Weekly Report: what happened at ORGS last week (1027-1031)?
Weekly Report · 11/03 10:25
Weekly Report: what happened at ORGS last week (1020-1024)?
Weekly Report · 10/27 10:28
Weekly Report: what happened at ORGS last week (1013-1017)?
Weekly Report · 10/20 10:25
Weekly Report: what happened at ORGS last week (1006-1010)?
Weekly Report · 10/13 10:28
More
About ORGS
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

Webull offers Orgenesis Inc stock information, including EXMKT: ORGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORGS stock methods without spending real money on the virtual paper trading platform.